In the BioHarmony Drug Report Database

"Preview" Icon

Buprenorphine

Butrans, Sublocade, Buvidal, Sixmo (buprenorphine) is a small molecule pharmaceutical. Buprenorphine was first approved as Butrans on 2010-06-30. It is used to treat heroin dependence and pain in the USA. It has been approved in Europe to treat opioid-related disorders. The pharmaceutical is active against mu-type opioid receptor and kappa-type opioid receptor. Buprenorphine hcl’s patents are valid until 2038-06-22 (FDA).

 

Trade Name

 

Buvidal, Sixmo
 

Common Name

 

buprenorphine
 

ChEMBL ID

 

CHEMBL511142
 

Indication

 

heroin dependence, opioid-related disorders, pain
 

Drug Class

 

Image (chem structure or protein)

Buprenorphine structure rendering